{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:28:22Z","timestamp":1790188102598,"version":"4.1.0"},"reference-count":65,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T00:00:00Z","timestamp":1547683200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0006919","type":"journal-article","created":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T18:29:18Z","timestamp":1547749758000},"page":"e0006919","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":89,"title":["Chikungunya as a paradigm for emerging viral diseases: Evaluating disease impact and hurdles to vaccine development"],"prefix":"10.1371","volume":"13","author":[{"given":"Giovanni","family":"Rezza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8016-8556","authenticated-orcid":true,"given":"Scott C.","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,1,17]]},"reference":[{"issue":"5","key":"ref1","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1473-3099(07)70107-X","article-title":"Chikungunya, an epidemic arbovirosis","volume":"7","author":"G Pialoux","year":"2007","journal-title":"The Lancet infect. Dis"},{"issue":"13","key":"ref2","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1056\/NEJMra1406035","article-title":"Chikungunya virus and the global spread of a mosquito-borne disease","volume":"372","author":"SC Weaver","year":"2015","journal-title":"N Engl J Med"},{"key":"ref3","article-title":"Principle and practice of Clinical Virology","author":"AJ Zuckerman","year":"2005"},{"key":"ref4","unstructured":"Chikungunya and dengue, south-west Indian Ocean. 2006. WHO Weekly Epidemiol. Record. 2006;81:105\u2013116."},{"issue":"8","key":"ref5","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1056\/NEJMp078013","article-title":"Chikungunya outbreaks\u2014the globalization of vectorborne diseases","volume":"356","author":"RN Charrel","year":"2007","journal-title":"N Engl J Med"},{"issue":"8","key":"ref6","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.3201\/eid2008.131615","article-title":"Co-circulation of Dengue and Chikungunya Viruses, Al Hudaydah, Yemen, 2012","volume":"20","author":"G Rezza","year":"2014","journal-title":"Emerg infect Dis"},{"issue":"13","key":"ref7","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2014.19.13.20752","article-title":"Emergence of chikungunya fever on the French side of Saint Martin island, October to December 2013","volume":"19","author":"S Cassadou","year":"2014","journal-title":"Euro Surveill"},{"issue":"9602","key":"ref8","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/S0140-6736(07)61779-6","article-title":"Infection with chikungunya virus in Italy: an outbreak in a temperate region","volume":"370","author":"G Rezza","year":"2007","journal-title":"Lancet"},{"key":"ref9","first-page":"22","article-title":"Detection of a chikungunya outbreak in Central Italy, August to September 2017","author":"G Venturi","year":"2017","journal-title":"Euro Surveill"},{"key":"ref10","unstructured":"Butler D. Health officials push for vaccine against neglected tropical virus. 2018. Available from: http:\/\/www.nature.com\/articles\/d41586-018-01637-7<\/ext-link>. [cited 2018 Dec 21]."},{"issue":"suppl 5","key":"ref11","doi-asserted-by":"crossref","first-page":"S488","DOI":"10.1093\/infdis\/jiw271","article-title":"Development of Vaccines for Chikungunya Fever","volume":"214","author":"JH Erasmus","year":"2016","journal-title":"J Infect Dis"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00104-16","article-title":"Vaccine and Therapeutic Options To Control Chikungunya Virus","volume":"31","author":"AM Powers","year":"2018","journal-title":"Clinical microbiology reviews"},{"issue":"37","key":"ref13","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1016\/j.vaccine.2017.07.065","article-title":"Regulatory considerations in development of vaccines to prevent disease caused by Chikungunya virus","volume":"35","author":"S Yang","year":"2017","journal-title":"Vaccine"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.coviro.2016.02.007","article-title":"Interspecies transmission and chikungunya virus emergence","volume":"16","author":"KA Tsetsarkin","year":"2016","journal-title":"Curr Opin Virol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.1038\/ncomms5084","article-title":"Multi-peaked adaptive landscape for chikungunya virus evolution predicts continued fitness optimization in Aedes albopictus mosquitoes","volume":"5","author":"KA Tsetsarkin","year":"2014","journal-title":"Nature Comm"},{"key":"ref16","first-page":"4","article-title":"The global distribution of the arbovirus vectors Aedes aegypti<\/italic> and Ae. albopictus<\/italic>","author":"MU Kraemer","year":"2015","journal-title":"Elife"},{"issue":"7","key":"ref17","doi-asserted-by":"crossref","DOI":"10.2807\/ese.13.07.08039-en","article-title":"Excess mortality as an epidemic intelligence tool in chikungunya mapping","volume":"13","author":"SK Ramchurn","year":"2008","journal-title":"Euro Surveill"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/rmv.606","article-title":"Chikungunya and the nervous system: what we do and do not know","volume":"19","author":"C Arpino","year":"2009","journal-title":"Rev Med Virol"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1212\/WNL.0000000000002234","article-title":"Chikungunya virus-associated encephalitis: A cohort study on La Reunion Island, 2005\u20132009","volume":"86","author":"P Gerardin","year":"2016","journal-title":"Neurology"},{"issue":"48","key":"ref20","doi-asserted-by":"crossref","first-page":"30079","DOI":"10.2807\/1560-7917.ES.2015.20.48.30079","article-title":"Increase in cases of Guillain-Barre syndrome during a Chikungunya outbreak, French Polynesia, 2014 to 2015","volume":"20","author":"E Oehler","year":"2015","journal-title":"Euro Surveill"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S1473-3099(07)70294-3","article-title":"Clinical burden of chikungunya virus infection","volume":"8","author":"B Queyriaux","year":"2008","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"e389","DOI":"10.1371\/journal.pntd.0000389","article-title":"Post-epidemic Chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period","volume":"3","author":"D Sissoko","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"issue":"1054","key":"ref23","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1136\/postgradmedj-2012-131477","article-title":"Prevalence of and risk factors for chronic arthralgia and rheumatoid-like polyarthritis more than 2 years after infection with chikungunya virus","volume":"89","author":"K Essackjee","year":"2013","journal-title":"Postgraduate Med J"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jinf.2012.04.005","article-title":"Long-term chikungunya infection clinical manifestations after an outbreak in Italy: a prognostic cohort study","volume":"65","author":"ML Moro","year":"2012","journal-title":"J Infect"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"e1197","DOI":"10.1371\/journal.pntd.0001197","article-title":"The Chikungunya epidemic on La Reunion Island in 2005\u20132006: a cost-of-illness study","volume":"5","author":"MK Soumahoro","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"ref26","unstructured":"Shepard DS. Cost and burden of dengue and chikungunya from the Americas to Asia. Dengue Bulletin 2010; 34. WHO Regional Office for South-East Asia, 2010."},{"key":"ref27","article-title":"The cost and burden of chikungunya in the Americas","author":"D Bloch","year":"2016"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1128\/AEM.19.2.321-325.1970","article-title":"Chikungunya virus vaccine prepared by Tween-ether extraction","volume":"19","author":"KH Eckels","year":"1970","journal-title":"Appl Microbiol"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"643","DOI":"10.4049\/jimmunol.107.3.643","article-title":"Production and evaluation of a formalin-killed Chikungunya vaccine","volume":"107","author":"VR Harrison","year":"1971","journal-title":"J Immunol"},{"issue":"18","key":"ref30","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1016\/j.vaccine.2009.02.062","article-title":"Assessment of immunogenic potential of Vero adapted formalin inactivated vaccine derived from novel ECSA genotype of Chikungunya virus","volume":"27","author":"M Tiwari","year":"2009","journal-title":"Vaccine"},{"issue":"43","key":"ref31","doi-asserted-by":"crossref","first-page":"6142","DOI":"10.1016\/j.vaccine.2012.07.072","article-title":"Evaluation of recombinant E2 protein-based and whole-virus inactivated candidate vaccines against chikungunya virus","volume":"30","author":"M Kumar","year":"2012","journal-title":"Vaccine"},{"issue":"3","key":"ref32","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0264-410X(86)90003-4","article-title":"Development of an attenuated strain of chikungunya virus for use in vaccine production","volume":"4","author":"NH Levitt","year":"1986","journal-title":"Vaccine"},{"issue":"6","key":"ref33","doi-asserted-by":"crossref","first-page":"681","DOI":"10.4269\/ajtmh.2000.62.681","article-title":"Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218","volume":"62","author":"R Edelman","year":"2000","journal-title":"Am J Trop Med Hyg"},{"issue":"11","key":"ref34","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1128\/JVI.06449-11","article-title":"Attenuation of Chikungunya virus vaccine strain 181\/clone 25 is determined by two amino acid substitutions in the E2 envelope glycoprotein","volume":"86","author":"R Gorchakov","year":"2012","journal-title":"J Virol"},{"issue":"3","key":"ref35","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/514240","article-title":"Immunologic interference from sequential administration of live attenuated alphavirus vaccines","volume":"177","author":"DJ McClain","year":"1998","journal-title":"J Infect Dis"},{"issue":"9","key":"ref36","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1586\/erv.12.84","article-title":"Chikungunya virus and prospects for a vaccine","volume":"11","author":"SC Weaver","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"ref37","article-title":"Chikungunya virus control: is a vaccine on the horizon?","author":"AM Powers","year":"2014","journal-title":"Lancet"},{"issue":"5","key":"ref38","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1128\/JVI.03453-13","article-title":"Novel attenuated Chikungunya vaccine candidates elicit protective immunity in C57BL\/6 mice","volume":"88","author":"D Hallengard","year":"2014","journal-title":"J Virol"},{"issue":"33","key":"ref39","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1016\/j.vaccine.2013.05.059","article-title":"Deciphering the protective role of adaptive immunity to CHIKV\/IRES a novel candidate vaccine against Chikungunya in the A129 mouse model","volume":"31","author":"H Chu","year":"2013","journal-title":"Vaccine"},{"issue":"12","key":"ref40","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1093\/infdis\/jiu014","article-title":"Chikungunya vaccine candidate is highly attenuated and protects nonhuman primates against telemetrically monitored disease following a single dose","volume":"209","author":"CJ Roy","year":"2014","journal-title":"J Infect Dis"},{"issue":"7","key":"ref41","doi-asserted-by":"crossref","first-page":"e1002142","DOI":"10.1371\/journal.ppat.1002142","article-title":"Novel chikungunya vaccine candidate with an IRES-based attenuation and host range alteration mechanism","volume":"7","author":"K Plante","year":"2011","journal-title":"PLoS Pathog"},{"issue":"9","key":"ref42","doi-asserted-by":"crossref","first-page":"e0004007","DOI":"10.1371\/journal.pntd.0004007","article-title":"Extended Preclinical Safety, Efficacy and Stability Testing of a Live-attenuated Chikungunya Vaccine Candidate","volume":"9","author":"KS Plante","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"ref43","first-page":"9","article-title":"Chikungunya Virus Strains Show Lineage-Specific Variations in Virulence and Cross-Protective Ability in Murine and Nonhuman Primate Models","author":"RM Langsjoen","year":"2018","journal-title":"MBio"},{"key":"ref44","article-title":"Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial","author":"K Ramsauer","year":"2015","journal-title":"Lancet infect Dis"},{"issue":"36","key":"ref45","doi-asserted-by":"crossref","first-page":"14622","DOI":"10.1073\/pnas.1204787109","article-title":"Eilat virus, a unique alphavirus with host range restricted to insects by RNA replication","volume":"109","author":"F Nasar","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"ref46","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1128\/JVI.01856-14","article-title":"Eilat virus host range restriction is present at multiple levels of the virus life cycle","volume":"89","author":"F Nasar","year":"2015","journal-title":"J Virol"},{"issue":"10","key":"ref47","doi-asserted-by":"crossref","first-page":"e0004119","DOI":"10.1371\/journal.pntd.0004119","article-title":"Utilization of an Eilat Virus-Based Chimera for Serological Detection of Chikungunya Infection","volume":"9","author":"JH Erasmus","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"ref48","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nm.4253","article-title":"A chikungunya fever vaccine utilizing an insect-specific virus platform","volume":"23","author":"JH Erasmus","year":"2017","journal-title":"Nat Med"},{"issue":"3","key":"ref49","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/nm.2105","article-title":"A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection","volume":"16","author":"W Akahata","year":"2010","journal-title":"Nat Med"},{"key":"ref50","article-title":"Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial","author":"LJ Chang","year":"2014","journal-title":"Lancet"},{"issue":"26","key":"ref51","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1016\/j.vaccine.2016.03.076","article-title":"Status of research and development of vaccines for chikungunya","volume":"34","author":"C Smalley","year":"2016","journal-title":"Vaccine"},{"issue":"4","key":"ref52","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1089\/vbz.2014.1681","article-title":"Therapeutics and vaccines against chikungunya virus","volume":"15","author":"T Ahola","year":"2015","journal-title":"Vector Borne Zoonotic Dis"},{"key":"ref53","first-page":"35","article-title":"Current research and clinical trials for a vaccine against chikungunya virus","volume":"3","author":"P Singh","year":"2013","journal-title":"Vaccine Development and Therapy"},{"issue":"6","key":"ref54","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028811","article-title":"Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination? The Risks of Incomplete Immunity to Dengue Virus Revealed by Vaccination","volume":"10","author":"SS Whitehead","year":"2018","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"9996","key":"ref55","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0140-6736(15)61117-5","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial","volume":"386","author":"AM Henao-Restrepo","year":"2015","journal-title":"Lancet"},{"issue":"7","key":"ref56","doi-asserted-by":"crossref","first-page":"e2331","DOI":"10.1371\/journal.pntd.0002331","article-title":"Dengue and other common causes of acute febrile illness in Asia: an active surveillance study in children","volume":"7","author":"MR Capeding","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"ref57","unstructured":"CFR-Code of Federal Regulations Title 21, Vol. 5. Revised as of April 21. Cite: 21CFR214. 2014."},{"issue":"1","key":"ref58","doi-asserted-by":"crossref","first-page":"e928","DOI":"10.1371\/journal.pntd.0000928","article-title":"A DNA vaccine against chikungunya virus is protective in mice and induces neutralizing antibodies in mice and nonhuman primates","volume":"5","author":"K Mallilankaraman","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"ref59","first-page":"25","article-title":"How the research-based industry approaches vaccine development and establishes priorities","volume":"110","author":"FE Andre","year":"2002","journal-title":"Dev Biol (Basel)"},{"issue":"4","key":"ref60","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1179\/2047773215Y.0000000017","article-title":"Do we need a vaccine against chikungunya?","volume":"109","author":"G Rezza","year":"2015","journal-title":"Pathog Glob Health"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"723","DOI":"10.2217\/fvl-2016-0067","article-title":"Vaccines against chikungunya, Zika and other emerging Aedes mosquito-borne viruses: unblocking existing bottlenecks","volume":"11","author":"G Rezza","year":"2016","journal-title":"Future Virol"},{"issue":"7","key":"ref62","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1080\/21645515.2017.1412024","article-title":"Funding vaccines for emerging infectious diseases","volume":"14","author":"G Wong","year":"2018","journal-title":"Hum Vaccin Immunother"},{"issue":"36","key":"ref63","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1016\/j.vaccine.2013.05.086","article-title":"A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus","volume":"31","author":"S Brandler","year":"2013","journal-title":"Vaccine"},{"issue":"22","key":"ref64","doi-asserted-by":"crossref","first-page":"13333","DOI":"10.1128\/JVI.01926-14","article-title":"Prime-boost immunization strategies against Chikungunya virus","volume":"88","author":"D Hallengard","year":"2014","journal-title":"J Virol"},{"key":"ref65","unstructured":"Chikungunya: Villepin refuse la pol\u00e9mique. Le Figaro. 15 October 2007. Available from: http:\/\/www.lefigaro.fr\/sciences\/2006\/02\/24\/01008-20060224ARTWWW91671-nouveau_bilan_cas.php<\/ext-link>. [cited 21 December 2018]."}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0006919","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T00:34:12Z","timestamp":1694565252000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0006919"}},"subtitle":[],"editor":[{"given":"David Joseph","family":"Diemert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,1,17]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0006919","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,17]]}}}